MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Continente #
EU - Europa 54.600
AS - Asia 4.796
NA - Nord America 2.430
SA - Sud America 419
AF - Africa 91
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 62.341
Nazione #
IT - Italia 53.839
US - Stati Uniti d'America 2.291
SG - Singapore 2.216
CN - Cina 1.250
VN - Vietnam 749
FR - Francia 394
BR - Brasile 260
HK - Hong Kong 164
BD - Bangladesh 92
DE - Germania 92
AR - Argentina 70
FI - Finlandia 59
CA - Canada 51
JP - Giappone 50
MX - Messico 47
IQ - Iraq 39
CH - Svizzera 38
IN - India 38
GB - Regno Unito 35
ID - Indonesia 35
EC - Ecuador 23
CO - Colombia 21
NL - Olanda 21
ZA - Sudafrica 19
ES - Italia 17
TH - Thailandia 15
UA - Ucraina 15
CL - Cile 13
PK - Pakistan 13
TR - Turchia 13
IE - Irlanda 12
PH - Filippine 12
RU - Federazione Russa 12
SA - Arabia Saudita 12
VE - Venezuela 12
KE - Kenya 11
MA - Marocco 11
TN - Tunisia 11
DZ - Algeria 10
TW - Taiwan 10
JM - Giamaica 9
JO - Giordania 9
UZ - Uzbekistan 9
HR - Croazia 8
PL - Polonia 8
EG - Egitto 7
KR - Corea 7
LT - Lituania 7
PY - Paraguay 7
AZ - Azerbaigian 6
IL - Israele 6
LB - Libano 6
NP - Nepal 6
SE - Svezia 6
AT - Austria 5
BO - Bolivia 5
CR - Costa Rica 5
GT - Guatemala 5
KG - Kirghizistan 5
MY - Malesia 5
PS - Palestinian Territory 5
KZ - Kazakistan 4
MN - Mongolia 4
NI - Nicaragua 4
PE - Perù 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
GH - Ghana 3
PA - Panama 3
PR - Porto Rico 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BY - Bielorussia 2
BZ - Belize 2
ET - Etiopia 2
GR - Grecia 2
HT - Haiti 2
LK - Sri Lanka 2
MU - Mauritius 2
OM - Oman 2
QA - Qatar 2
SO - Somalia 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
Totale 62.313
Città #
Genova 35.457
Genoa 11.092
Rapallo 4.076
Vado Ligure 2.943
Singapore 1.065
San Jose 921
Lauterbourg 377
Ashburn 243
Ho Chi Minh City 217
Beijing 198
Hanoi 171
Hong Kong 152
New York 142
Santa Clara 82
Bordighera 80
Frankfurt am Main 74
Helsinki 59
Tokyo 41
Los Angeles 40
Council Bluffs 37
Da Nang 35
Haiphong 35
Zurich 35
Mexico City 31
São Paulo 29
Orem 26
Rome 26
Tianjin 26
Buffalo 21
Atlanta 20
Dallas 18
Amsterdam 16
Biên Hòa 15
Milan 14
Shanghai 14
Johannesburg 13
Baghdad 12
Montreal 12
Dublin 11
Phoenix 11
Brooklyn 10
Houston 10
Nuremberg 10
Can Tho 9
Chicago 9
Des Moines 9
Hải Dương 9
Nairobi 9
Amman 8
Chennai 8
City of London 8
Kingston 8
Madrid 8
Naples 8
Phủ Lý 8
Tashkent 8
Toronto 8
Warsaw 8
Curitiba 7
Denver 7
Guangzhou 7
Ninh Bình 7
San Francisco 7
Santiago 7
Thái Nguyên 7
Baku 6
Bogotá 6
Buenos Aires 6
Caracas 6
Cardiff 6
Charlotte 6
Guayaquil 6
Jakarta 6
Paris 6
Shenzhen 6
Washington 6
Bari 5
Brasília 5
Calgary 5
Changsha 5
Columbus 5
Contagem 5
Detroit 5
Dhaka 5
Jeddah 5
Karbala 5
Long Xuyen 5
Newark 5
Quảng Ngãi 5
Stockholm 5
Thái Bình 5
Zagreb 5
Bangkok 4
Belo Horizonte 4
Bắc Giang 4
Bắc Ninh 4
Catania 4
Cincinnati 4
Dakar 4
Fresno 4
Totale 58.269
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 273
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 263
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 241
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 239
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 238
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 235
Dysimmune mononeuropathies: A diagnosis not to be missed 232
A normative study of the Italian printed word version of the free and cued selective reminding test 228
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 227
Neural correlates of ankle movements during different motor tasks: A feasibility study 222
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 219
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 218
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 218
Clinical epidemiology of ALS in Liguria, Italy. 217
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 215
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 214
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 208
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 205
Basal ganglia are active during motor performance recovery after a demanding motor task. 204
Different MRI patterns in MS worsening after stopping fingolimod 204
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 203
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 203
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 203
Neural correlates of lower limbs proprioception: An fMRI study of foot position matching 203
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 202
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 201
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 201
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 201
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 201
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 200
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 200
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 200
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 199
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 198
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis 194
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 193
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 191
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 190
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 190
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 189
Evidence for aerobic ATP synthesis in isolated myelin vesicles 189
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 189
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 188
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 188
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 188
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 187
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 186
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 186
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. 185
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 185
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 184
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 184
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 182
Delirium in the acute phase after stroke: comparison between methods of detection 182
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 181
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 181
Direct immunofluorescence in sural nerve biopsies. 180
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 179
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 179
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 179
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 178
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 178
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 178
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 178
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 177
Screening, diagnosis, and management of obstructive sleep apnea in dangerous-goods truck drivers: to be aware or not? 177
GFAP expression of human Schwann cells in tissue culture. 176
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 176
National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage 176
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 176
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 175
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 175
Teriflunomide treatment reduces B cells in patients with MS. 175
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 174
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 174
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 173
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 173
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 173
A prospective study of acute idiopathic neuropathy II antecedent events. 173
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 173
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 173
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis 172
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 172
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 172
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 171
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 170
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 170
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 170
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 170
[Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?]. 170
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 170
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 169
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 169
Three years of experience: the Italian registry and safety data update 169
Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. 169
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 169
Neurological research in Italy in 2003 and 2004. 168
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 168
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 168
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 168
Totale 19.069
Categoria #
all - tutte 188.560
article - articoli 171.957
book - libri 862
conference - conferenze 14.373
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.368
Totale 377.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021261 0 0 0 0 0 0 0 0 0 0 0 261
2021/20225.493 165 399 656 695 170 292 287 1.250 217 494 152 716
2022/20234.881 491 396 58 467 803 858 20 370 854 27 467 70
2023/20242.539 154 340 64 283 190 521 201 152 131 35 122 346
2024/20257.294 248 564 249 465 989 778 631 1.134 324 335 627 950
2025/202612.204 1.593 388 745 1.100 1.688 1.292 2.079 582 799 1.171 565 202
Totale 62.911